Product
LY3556050
Aliases
LY3556050 ISA
6 clinical trials
7 indications
Indication
Diabetic Peripheral NeuropathyIndication
OsteoarthritisIndication
KneeIndication
painful diabetic neuropathyIndication
Low Back PainIndication
Diabetic Peripheral Neuropathic PainIndication
HealthyClinical trial
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic PainStatus: Recruiting, Estimated PCD: 2025-01-17
Clinical trial
A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic PainStatus: Recruiting, Estimated PCD: 2027-04-25
Clinical trial
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic PainStatus: Terminated, Estimated PCD: 2022-06-13
Clinical trial
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis PainStatus: Completed, Estimated PCD: 2021-10-21
Clinical trial
An Open-Label Study in Healthy Participants to Evaluate the Effect of LY3556050 on Metformin PharmacokineticsStatus: Completed, Estimated PCD: 2022-12-27
Clinical trial
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back PainStatus: Completed, Estimated PCD: 2022-02-09